| ABSTRACT Objective:To investigate the utilization condition of nucleosides anti hepatitis drug in our hospital from 2013 to 2017, the characteristics and tendency so as to provide references for the rational use and scientific management of nucleosides anti hepatitis drug. Methods:The consumption data about nucleosides anti hepatitis drug in our hospital during 2013 2017 were collected for analysis of categories, consumption sum, DDDs and DDC etc. Results:From 2013 to 2017, the consumption of five nucleosides anti hepatitis drug increased year by year, with Tenofovir disoproxil fumarate having the highest increase of 21.75 times. In the 5 nucleoside anti hepatitis drugs, consumption sum, constituent ratio and DDDs of Entecavir were all top of the list, the amount of sales increased year by year, an increase of 0.75 times. Tenofovir disoproxil fumarate had the biggest increase of consumption sum and DDDs in the five years, increased by 6.29 fold and 21.75 fold. DDC of the 5 nucleoside anti hepatitis drugs gradually decreased, Tenofovir disoproxil fumarate had the biggest decrease of DDC with 68%.Conclusion:The utilization of nucleosides anti hepatitis drug is getting more and more standard, and these drugs are still the main drug for treatment of viral hepatitis, and Tenofovir will play a greater role in clinical practice. |
